The automated and closed cell therapy market is anticipated to grow at a CAGR of 22.05% during the forecast period.
— Knowledge Sourcing Intelligence
NOIDA, UTTAR PARDESH, INDIA, November 27, 2023 /EINPresswire.com/ — According to a new study published by Knowledge Sourcing Intelligence, the automated and closed cell therapy market is projected to grow at a CAGR of 22.05% between 2021 and 2028.
The rising global cancer incidence is a major driving force behind the rapid growth of the automated and closed-cell therapy markets. According to the World Health Organization (WHO), Cancer is the main cause of death in the world, accounting for nearly 10 million deaths in 2020, or approximately one in every six, around 400,000 children are diagnosed with cancer every year. The most common cancers differ by country. Cervical cancer is the most prevalent kind of cancer in 23 countries.
Automated and closed-cell therapy involves using technological advances to automate multiple phases of cell therapy production, ensuring safety, consistency, and efficiency. This system encompasses diverse methods using cell therapy and regenerative medicines to cure cancer cells. The market is witnessing substantial growth due to the increasing demand for regenerative medicine and cell therapies has positively impacted the demand for automated and closed cell therapy.
Numerous product launches and technological advancements are taking place in the market. For instance, in April 2022, Lonza expanded the abilities of the Cocoon® Platform by releasing the second-generation tool, which includes new integrated capabilities in cell binding, cell division, and bead elimination. In March 2022, MiltenyiBiotec Seven university hospitals in NRW established an infrastructure network to support the launch of new cell therapies against COVID-19 and forthcoming viral global epidemics.
Access sample report or view details: https://www.knowledge-sourcing.com/report/automated-and-closed-cell-therapy-market
The automated and closed cell therapy market, based on workflow is segmented into, six main categories namely separation, expansion, apheresis, fill-finish, cryopreservation, and others.
The automated and closed cell therapy market, based on type is segmented into, two main categories namely stem cell therapy and non-stem cell therapy.
The automated and closed cell therapy market, based on the scale is segmented into, two main categories namely pre-commercial/R&D scale, and commercial scale.
North America is poised to experience substantial growth. Significant technological advancements and increasing cancer cases in the region are driving the growth of the automated and closed-cell therapy market. For instance, according to the American Cancer Society, cancer remains the second leading cause of death in the United States, behind only heart disease. In 2022, the United States is expected to see 1.9 million new cancer cases and 609,360 cancer deaths, for a total of 1,670 deaths per day.
The research includes coverage of MiltenyiBiotec, Lonza, Fresenius Kabi, Cytiva (Danaher Corp.), BioSpherix, Ltd., Terumo Corporation, Sartorius AG, ThermoGenesis Holdings, Inc., Cellares Inc., and Thermo Fisher Scientific, Inc. as the significant market players in the automated and closed cell therapy market.
The market analytics report segments the automated and closed cell therapy market using the following criteria:
• By Workflow
o Separation
o Expansion
o Apheresis
o Fill-Finish
o Cryopreservation
o Others
• By Type
o Stem Cell Therapy
o Non-Stem Cell Therapy
• By Scale
o Pre-commercial/R&D Scale
o Commercial Scale
• By Geography
o North America
• United States
• Canada
• Mexico
o South America
• Brazil
• Argentina
• Others
o Europe
• United Kingdom
• Germany
• France
• Spain
• Others
o Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
o Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others
Companies Profiled:
• MiltenyiBiotec
• Lonza
• Fresenius Kabi
• Cytiva (Danaher Corp.)
• BioSpherix, Ltd.
• Terumo Corporation
• Sartorius AG
• ThermoGenesis Holdings, Inc.
• Cellares Inc.
• Thermo Fisher Scientific, Inc.
Explore More Reports
• Global Gene Therapy Market: https://www.knowledge-sourcing.com/report/global-gene-therapy-market
• Cancer Gene Therapy Market: https://www.knowledge-sourcing.com/report/cancer-gene-therapy-market
• Stem Cell Therapy For Wound Healing Market: https://www.knowledge-sourcing.com/report/stem-cell-therapy-for-wound-healing-market
Ankit Mishra
Knowledge Sourcing Intelligence LLP
+1 850-250-1698
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
